Opening book details…
About this Medicine article
Cost-effectiveness of natalizumab vs fingolimod for the treatment of relapsing-remitting multiple sclerosis: analyses in Sweden by O’Day, Ken; Meyer, Kellie; Stafkey-Mailey, Dana; Watson, Crystal is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- O’Day, Ken; Meyer, Kellie; Stafkey-Mailey, Dana; Watson, Crystal
- Publisher
- Informa plc; Informa UK (Taylor & Francis); Taylor & Francis; Informa UK Limited; Informa Healthcare (ISSN 1369-6998)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)
More by O’Day, Ken; Meyer, Kellie; Stafkey-Mailey, Dana; Watson, Crystal
Browse all works by O’Day, Ken; Meyer, Kellie; Stafkey-Mailey, Dana; Watson, Crystal